Transforming molecular neuropathology for adult brain tumor patients in the UK: Insights on implementation, adoption, and patient access (2021-2024)
Kathreena M. Kurian, Andrew P Wright, Fereshteh Sari, Mayen Briggs et autres
BackgroundMolecular neuropathology is evolving rapidly, driven by novel genomic technologies, national policies, and the urgent need for precision brain tumor care. Inequity in access to genomic testing highlighted in previous reports warrants further investigation. Methods: We analyzed anonymized data from 21 United …
gb (code pays fourni par la source)